COMPANY PROFILE

Cannalysis

Explore full profile

Cannabis Testing Laboratory

Santa Ana, United StatesFounded 2015Biotech & Life Sciences

Valuation $100–250M Last recorded · 2019

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Cannalysis

Cannalysis Labs is a premier analytical cannabis laboratory based in Southern California, fully licensed and ISO IEC 17025 accredited. The company specializes in providing precise and validated scientific methods to analyze cannabis products for a diverse range of clients, including cultivators, manufacturers, dispensaries, and individual consumers. Operating in the burgeoning cannabis market, Cannalysis Labs ensures the safety and quality of cannabis products by testing for harmful mycotoxins and other contaminants. The business model revolves around offering comprehensive testing services, which are critical for regulatory compliance and consumer safety. Cannalysis Labs generates revenue through service fees charged for each analysis conducted. The company also offers an online platform that provides customers with total control over their data, allowing for easy access and management of test results. This platform supports various data display options, including customized product labels, dispensary displays, and encrypted private storage. By focusing on accuracy, specificity, and ease of use, Cannalysis Labs aims to be the go-to solution for cannabis testing needs in Southern California.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2015
Headquarters: Santa Ana, United States
Employees: 6
Open positions: None listed
Dealroom signal: 56.3/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Testing, Biotechnology, Cannabis, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Sep 2019	$23M	$90M	CanLab	↗
SEED✓Equity / VC	Nov 2017	—	—	Casa Verde Capital	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Cannalysis website traffic

Latest recorded traffic for Cannalysis is 7.6K monthly website visits, up 4122.2% over the last three months. Cannalysis's team grew 0% over the past year.

Latest monthly visits7.6K 3-month web change+4122.2% 1-year team growth0%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CTCultivation TechnologiesInfrastructure, genetics, technology, and branding to the legal medical cannabis industry	Irvine, United States	Operational	2	$10K	—
SLSteep Hill LabsGlobal leader in cannabis testing and analytics \| CA \| CO \| NV \| WA \| Phone: +1 (800) 658-0955 \| Email: [email protected]	Berkeley, United States	Operational
LELeafWorksProvides plant DNA testing for natural herbal industries to ensure accurate labeling of products	Sebastopol, United States	Operational
PBPhylos BioscienceCannabis genetics company that empowers growers of all sizes to produce high quality cannabis in a cost-effective way	Portland, United States	Operational
LALabConnectLabConnect enhances lives by collaborating with pharma/biotech firms and CROs to speed up global medicine development	Johnson City, United States	Operational
TLT3 LabsProvide high-value pre-clinical GLP compliant testing and training services to medical device, biologics, and pharmaceutical develope	Atlanta, United States	Acquired
PRProterixBioDeveloping innovative products to transform the management of chronic diseases	Billerica, United States	Closed
DADiabetes AmericaDiabetes America, Inc, doing business as DCOA-Texas, Inc., operates a network of diabetes care and management centers in the United	Houston, United States	Operational